At Advanced Accelerator Applications, we are reimagining nuclear medicine and cancer care. Our mission is to transform patients’ lives by developing and delivering targeted radioligand therapies and precision diagnostic solutions for oncology.
Advanced Accelerator Applications是一家放射性药物研发商,公司开发了一种用于肿瘤适应症的治疗配对管道,主要产品包括正电子发射断层扫描和单光子发射计算机断层扫描的分子核诊断放射性药物等,集中应用于临床肿瘤学、心脏病学、神经病学和感染性、炎症性疾病的诊断领域。近日,西门子医疗宣布,已完成对诺华旗下Advanced Acceler...
Advanced Accelerator Applications SA ADR(AAAP)股吧,股民朋友可以在这里畅所欲言,分析讨论股票名的最新动态。东方财富股吧,专业的股票论坛社区。
雪球为您提供Advanced Accelerator(AAAP)股票实时行情,资金流向,新闻资讯,研究报告,社区互动,交易信息,个股点评,公告,财务指标分析等与Advanced Accelerator(AAAP)股票相关的信息与服务.
Advanced Accelerator Applications是一家放射性药物研发商,公司开发了一种用于肿瘤适应症的治疗配对管道,主要产品包括正电子发射断层扫描和单光子发射计算机断层扫描 ...
By accessing and browsing this Site, you accept, without limitation or qualification, these Terms and Conditions and acknowledge that any other agreements regarding the use of this Site between you and Advanced Accelerator Applications SA are superseded and of no force or effect. 2. Use of ...
Publisher:Advanced Accelerator Applications SA, a limited liability company (“société anonyme” “SA”), incorporated under the laws of France, with a share capital of EUR 9,641,449.20, registered under number 441 417 110 (R.C.S. Bourg-en-Bresse), having its registered office at 8 rue ...
证券名称Advanced Accelerator Applications SA ADR 证券类型美国存托凭证 上市场所纳斯达克交易所 上市板块主板 发行方式公开发售 首发上市日2015-11-11 首发价格(元)16 USD 首发数量(股)4688000 首发募资额(元)75,008,000.00 USD 首发主承销商Jefferies LLC,Citigroup Global Markets Inc ...
JXHB2300155 177Lu-PSMA-617注射液 化药1 补充申请 2023-09-28 Novartis Pharma AG;Advanced Accelerator Applications (Italy) S.R.L.;Advanced Accelerator Applications Ibérica, S.L.U. 补充申请 查看 查看 JXHL2200270 镥(177Lu)vipivotide tetraxetan注射液 化药5.1 进口 2022-09-03 Advanced Accelerator ...
In recent trading, shares of Advanced Accelerator Applications SA (Symbol: AAAP) have crossed above the average analyst 12-month target price of.